A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, rifampicin-resistant tuberculosis, tuberculosis	Not yet recruiting	Phase 3	2026-06-30		NCT07675954

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Desmond Tutu TB Centre	2
Korea University	12
National Institute of Health, Korea	5
Perinatal HIV Research Unit of the University of the Witswatersrand	5
Seoul National University	14
Seoul National University Hospital	277

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Desmond Tutu TB Centre, Brooklyn Chest Hospital Trial Unit	Cape Town	South Africa	1
Perinatal HIV Research Unit, PHRU-Matlosana, Tshepong Hospital	Klerksdorp	South Africa	1